Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04843501 · ClinicalTrials.gov registry record · NA
Middle School Cluster Randomized Controlled Trial (RCT) to Evaluate E-Cigarette Prevention Program: CATCH My Breath
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 2,059
- Enrollment target
NCT04843501: Completed NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT04843501 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 2,059 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04843501, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,059 participants
- Enrollment target
Study Summary
This is a two-arm, cluster randomized trial designed to to evaluate the effectiveness of an e-cigarette curriculum \[called the CATCH My Breath (CMB) program\] in delaying the onset of e-cigarette use in middle schoolers. Schools will be assigned to either the CMB program or usual care, which is Texas Education Agency (TEA) required tobacco prevention program. 10 schools will be assigned to each arm arm, and each school will include 70 students in the study, for a total of 700 students per arm and 1400 total students in the study. Both programs will be administered to participating students over 3 years.
Primary Outcome
Current use is defined as e-cigarette use in the last 30 days.
Interventions
- BEHAVIORAL CATCH My Breath (CMB) program for E-cigarette prevention among adolescents
- BEHAVIORAL Texas Education Agency (TEA) required tobacco prevention program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,059 participants |
| Start Date | 2020-12-13 |
| Est. Completion | 2024-12-30 |
| Phase | NA |
What the finished NCT04843501 record still lists
NCT04843501 is an interventional study that assigns participants to a tested intervention. Its 2,059 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% higher).
The record links to 0 conditions, and to 2 interventions - of which CATCH My Breath (CMB) program for E-cigarette prevention among adolescents is the first listed.
NCT04843501 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04843501 about?
NCT04843501 is a clinical study titled "Middle School Cluster Randomized Controlled Trial (RCT) to Evaluate E-Cigarette Prevention Program: CATCH My Breath". This is a two-arm, cluster randomized trial designed to to evaluate the effectiveness of an e-cigarette curriculum \[called the CATCH My Breath (CMB) program\] in delaying the onset of e-cigarette use in middle schoolers. Schools will be assigned to either the CMB program or usual care, which is Tex...
What is the current status of trial NCT04843501?
This trial is currently completed. It is a NA study. The enrollment target is 2,059 participants. The study started on 2020-12-13. Estimated completion is 2024-12-30.
What interventions are being tested in trial NCT04843501?
The interventions under investigation include: CATCH My Breath (CMB) program for E-cigarette prevention among adolescents (BEHAVIORAL), Texas Education Agency (TEA) required tobacco prevention program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04843501?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04843501's enrollment target sits among peer trials
2,059 51st of 2000 higher than 1,950 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04871542 · 2,062 participants
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
- NCT06521944 · 2,062 participants
RSV Vaccine Pregnancy Registry
- NCT07168993 · 2,063 participants · NA
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
- NCT06666192 · 2,067 participants · NA
The Ohio State University (OSU) SCREEN Community Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI